View Filing Data

265,000

165,000

200,285

1,747,658

1,440,399

(112,484)

(103,737)

Cash and cash equivalents

1,635,174

1,336,662

126,500

102,726

^[1]

33,650

29,862

35,493

33,993

165,207

74,839

52,438

43,792

2,048,462

1,621,874

Liabilities

^[1]

900,225

689,849

62,278

51,125

22,544

23,307

28,668

28,778

1,013,715

793,059

Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding

Common stock, $0.001 par value. Authorized 250,000 shares; issued and outstanding - 134,524 shares at March 31, 2012, and 110,786 shares at December 31, 2011

134

111

Additional paid in capital

1,277,283

1,055,256

Distributions in excess of net income

(230,676)

(214,059)

Accumulated other comprehensive loss

(11,732)

(12,231)

Treasury shares, at cost

(262)

Total Medical Properties Trust, Inc. stockholders' equity

1,034,747

828,815

Non-controlling interests

1,034,747

828,815

MPT Operating Partnership, L.P. [Member]

2,048,462

1,621,874

Real estate assets

Land, buildings and improvements and intangible lease assets

1,282,373

1,275,399

265,000

165,000

200,285

1,747,658

1,440,399

(112,484)

(103,737)

Cash and cash equivalents

1,635,174

1,336,662

126,500

102,726

33,650

29,862

35,493

33,993

165,207

74,839

52,438

43,792

2,048,462

1,621,874

Liabilities

900,225

689,849

34,768

28,780

22,544

23,307

Payable due to Medical Properties Trust, Inc.

28,668

28,778

27,120

21,955

1,013,325

792,669

General Partner - issued and outstanding - 1,344 units at March 31, 2012 and 1,107 units at December 31, 2011

10,472

8,418

Accumulated other comprehensive loss

(11,732)

(12,231)

Total MPT Operating Partnership capital

1,035,137

829,205

Non-controlling interests

Total capital

1,035,137

829,205

MPT Operating Partnership, L.P. [Member] | Common Units [Member]

2,048,462

1,621,874

MPT Operating Partnership, L.P. [Member] | LTIP Units [Member]

Limited Partners Capital

1,036,397

833,018

Limited Partners Capital

[1]	Level II: Fair value based on quoted prices for similar or identical instruments in active or inactive markets, respectively, or calculated utilizing model-derived valuations in which significant inputs or value drivers are observable in active markets.

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2012	Dec. 31, 2011
Equity/Capital
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	134,524,000	110,786,000
Common stock, shares outstanding	134,524,000	110,786,000
MPT Operating Partnership, L.P. [Member]
Equity/Capital
Common stock, shares issued	23,575,000
General Partner, units issued	1,344,000	1,107,000
General Partner, units outstanding	1,344,000	1,107,000
MPT Operating Partnership, L.P. [Member] \| Common Units [Member]
Equity/Capital
Limited Partners, units issued	133,180,000	109,679,000
Limited Partners, units outstanding	133,180,000	109,679,000
MPT Operating Partnership, L.P. [Member] \| LTIP Units [Member]
Equity/Capital
Limited Partners, units issued	150,000	150,000
Limited Partners, units outstanding	150,000	150,000

Condensed Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenues
Rent billed	$ 32,165	$ 27,355
Straight-line rent	1,449	1,710
Income from direct financing leases	1,835
Interest and fee income	7,942	5,282
Total revenues	43,391	34,347
Expenses
Real estate depreciation and amortization	8,746	7,570
Property-related	331	58
General and administrative	7,592	6,874
Acquisition expenses	3,425	2,040
Total operating expenses	20,094	16,542
Operating income	23,297	17,805
Other income (expense)
Interest income (expense) and other	(16)	(14)
Interest expense	(12,796)	(8,139)
Net other expense	(12,812)	(8,153)
Income from continuing operations	10,485	9,652
Income from discontinued operations	121	1,172
Net income	10,606	10,824
Net income (loss) attributable to non-controlling interests	(42)	(44)
Net income attributable to MPT Operating Partnership partners	$ 10,564	$ 10,780
Earnings per common share/unit - basic and diluted
Income (loss) from continuing operations attributable to MPT Operating Partnership partners	$ 0.08	$ 0.08
Income from discontinued operations attributable to MPT Operating Partnership partners		0.01
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.08	$ 0.09
Weighted average units outstanding:
Basic	124,906	110,400
Diluted	124,906	110,408
Dividends declared per common share/unit	$ 0.20	$ 0.20
MPT Operating Partnership, L.P. [Member]
Revenues
Rent billed	$ 32,165	$ 27,355
Straight-line rent	1,449	1,710
Income from direct financing leases	1,835
Interest and fee income	7,942	5,282
Total revenues	43,391	34,347
Expenses
Real estate depreciation and amortization	8,746	7,570
Property-related	331	58
General and administrative	7,592	6,858
Acquisition expenses	3,425	2,040
Total operating expenses	20,094	16,526
Operating income	23,297	17,821
Other income (expense)
Interest income (expense) and other	(16)	(14)
Interest expense	(12,796)	(8,139)
Net other expense	(12,812)	(8,153)
Income from continuing operations	10,485	9,668
Income from discontinued operations	121	1,172
Net income	10,606	10,840
Net income (loss) attributable to non-controlling interests	(42)	(44)
Net income attributable to MPT Operating Partnership partners	$ 10,564	$ 10,796
Earnings per common share/unit - basic and diluted
Income (loss) from continuing operations attributable to MPT Operating Partnership partners	$ 0.08	$ 0.08
Income from discontinued operations attributable to MPT Operating Partnership partners		0.01
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.08	$ 0.09
Weighted average units outstanding:
Basic	124,906	110,400
Diluted	124,906	110,408
Dividends declared per common share/unit	$ 0.20	$ 0.20

Condensed Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Net income	$ 10,606	$ 10,824
Other comprehensive income:
Unrealized gain on interest rate swap	499	517
Total comprehensive income	11,105	11,341
Comprehensive income attributable to non-controlling interests	(42)	(44)
Comprehensive income attributable to MPT common stockholders	11,063	11,297
MPT Operating Partnership, L.P. [Member]
Net income	10,606	10,840
Other comprehensive income:
Unrealized gain on interest rate swap	499	517
Total comprehensive income	11,105	11,357
Comprehensive income attributable to non-controlling interests	(42)	(44)
Comprehensive income attributable to MPT common stockholders	$ 11,063	$ 11,313

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 8, 9, 10, 11, 12, 13, 14
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 30
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A5
-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e557-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e540-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6508144

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to noncontrolling interests, if any. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

Change in accumulated gains and losses from derivative instrument designated and qualifying as the effective portion of cash flow hedges, net of tax effect. The after tax effect change includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 24
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 17, 20
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 121
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624171-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A1, A4, A5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Operating activities
Net income	$ 10,606	$ 10,824
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	8,909	8,084
Straight-line rent revenue	(1,449)	(1,735)
Share-based compensation	1,858	1,838
Increase accounts payable and accrued liabilities	6,882	2,331
Amortization and write-off of deferred financing costs and debt discount	856	986
Increase in interest and rent receivable	(3,787)	(801)
Other adjustments	(523)	(2,241)
Net cash provided by operating activities	23,352	19,286
Investing activities
Real estate acquired	(671)	(173,486)
Principal received on loans receivable	1,184	580
Investment in loans receivable direct financing leases, and other investments	(396,500)	(5,463)
Construction in progress and other	(5,422)	(4,647)
Net cash used for investing activities	(401,409)	(183,016)
Financing activities
Revolving credit facilities, net	(89,600)	98,400
Additions to term debt	300,000
Payments of term debt	(58)	(6,945)
Distributions paid	(22,412)	(22,374)
Sale of common stock, net	220,193
Lease deposits and other obligations to tenants	(110)	3,612
Debt issuance costs paid and other financing activities	(6,182)	(361)
Net cash provided by financing activities	401,831	72,332
Increase (decrease) in cash and cash equivalents for period	23,774	(91,398)
Cash and cash equivalents at beginning of period	102,726	98,408
Cash and cash equivalents at end of period	126,500	7,010
Interest paid	3,202	5,261
Supplemental schedule of non-cash investing activities:
Real estate acquired via assumption of mortgage loan		(14,592)
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	27,182	22,403
Assumption of mortgage loan (as part of real estate acquired)		14,592
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	10,606	10,840
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	8,909	8,084
Straight-line rent revenue	(1,449)	(1,735)
Share-based compensation	1,858	1,838
Increase accounts payable and accrued liabilities	6,882	2,331
Amortization and write-off of deferred financing costs and debt discount	856	970
Increase in interest and rent receivable	(3,787)	(801)
Other adjustments	(523)	(2,241)
Net cash provided by operating activities	23,352	19,286
Investing activities
Real estate acquired	(671)	(173,486)
Principal received on loans receivable	1,184	580
Investment in loans receivable direct financing leases, and other investments	(396,500)	(5,463)
Construction in progress and other	(5,422)	(4,647)
Net cash used for investing activities	(401,409)	(183,016)
Financing activities
Revolving credit facilities, net	(89,600)	98,400
Additions to term debt	300,000
Payments of term debt	(58)	(6,945)
Distributions paid	(22,412)	(22,374)
Sale of common stock, net	220,193
Lease deposits and other obligations to tenants	(110)	3,612
Debt issuance costs paid and other financing activities	(6,182)	(361)
Net cash provided by financing activities	401,831	72,332
Increase (decrease) in cash and cash equivalents for period	23,774	(91,398)
Cash and cash equivalents at beginning of period	102,726	98,408
Cash and cash equivalents at end of period	126,500	7,010
Interest paid	3,202	5,261
Supplemental schedule of non-cash investing activities:
Real estate acquired via assumption of mortgage loan		(14,592)
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	$ 27,182	22,403
Assumption of mortgage loan (as part of real estate acquired)		$ 14,592

Organization	3 Months Ended
Organization	Mar. 31, 2012
Organization [Abstract]
Organization	1. Organization Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003 under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist. We have operated as a real estate investment trust ("REIT") since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as a taxable REIT subsidiaries ("TRSs"). Our TRSs are subject to both federal and state income taxes. Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment.

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Name Statement of Position (SOP)
-Publisher AICPA
-Number 94-6
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Name FASB Interpretation (FIN)
-Publisher FASB
-Number 46R
-Paragraph 4, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 915
-SubTopic 235
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 272
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 15
-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph 8, C1, C7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

3 Months Ended

Mar. 31, 2012

Summary Of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012. The condensed consolidated balance sheet at December 31, 2011 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K, as amended, for the year ended December 31, 2011. During the three months ended March 31, 2012, there were no material changes to these policies, except we began using direct finance lease ("DFL") accounting with the acquisition and lease of the real estate of Ernest Health, Inc. ("Ernest"). Under DFL accounting, future minimum lease payments are recorded as a receivable. Unearned income, which represents the net investment in the DFL less the sum of minimum lease payments receivable and the estimated residual values of the leased properties, is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized and unearned income. DFLs are placed on non-accrual status when management determines that the collectability of contractual amounts is not reasonably assured. While on non-accrual status, DFLs are accounted for on a cash basis, in which income is recognized only upon receipt of cash.

For our equity interest in Ernest and related loans (as more fully described in Note 3), we have elected to account for these investments at fair value due to size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans made prior to 2012

Variable Interest Entities

In regards to the Ernest Transaction, we have determined that Ernest is a variable interest entity ("VIE"); however, we are not the primary beneficiary as we lack the ability to direct the activities of Ernest that most significantly impact the entity's economic performance. At March 31, 2012, we had loans and/or equity investments in several VIEs for which we are not the primary beneficiary. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at March 31, 2012 (in thousands):


VIE Type	Maximum Loss Exposure(1)	Asset Type Classification	Carrying Amount(2)
Loans, net	$263,977	Mortgage and other loans	$231,568
Equity investments	$ 13,220	Other assets	$ 2,751

(1)

Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represent the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrower or investee) that most significantly impact the VIE's economic performance. As of March 31, 2012, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).

Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Recent Accounting Pronouncement. In June 2011, the FASB issued Accounting Standards Update No. 2011-05, Presentation of Comprehensive Income ("ASU 2011-05"). The amendments require that all non-owner changes in stockholders' equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income and the total of comprehensive income. In December 2011, the FASB deferred portions of this update in its issuance of Accounting Standards Update No. 2011-12 (see discussion below). The Company has elected the two-statement approach and the required financial statements are presented herein.

Real Estate And Lending Activities

3 Months Ended

Mar. 31, 2012

Real Estate And Lending Activities [Abstract]

Real Estate And Lending Activities

3. Real Estate and Lending Activities

Acquisitions

2012 Activity

On February 29, 2012, we made loans to and acquired assets from Ernest for a combined purchase price and investment of $396.5 million, consisting of $200 million to purchase real estate assets, a first mortgage loan of $100 million, an acquisition loan for $93.2 million and a capital contribution of $3.3 million ("Ernest Transaction").

Real Estate Acquisition and Mortgage Loan Financing

Pursuant to a definitive real property asset purchase agreement (the "Purchase Agreement"), we acquired from Ernest and certain of its subsidiaries (i) a portfolio of five rehabilitation facilities (including a ground lease interest relating to a community-based acute rehabilitation facility in Wyoming), (ii) seven long-term acute care facilities located in seven states and (iii) undeveloped land in Provo, Utah (collectively, the "Acquired Facilities") for an aggregate purchase price of $200 million, subject to certain adjustments. The Acquired Facilities are leased to subsidiaries of Ernest pursuant to a master lease agreement. The master lease agreement has a 20-year term with three five-year extension options and provides for an initial rental rate of 9%, with consumer price-indexed increases, limited to a 2% floor and 5% ceiling annually thereafter. In addition, we made Ernest a $100 million loan secured by a first mortgage interest in four subsidiaries of Ernest, which has terms similar to the leasing terms described above.

Acquisition Loan and Equity Contribution

Through an affiliate of one of our TRSs, we made investments of approximately $96.5 million in Ernest Health Holdings, LLC ("Ernest Holdings"), which is the owner of Ernest. These investments, which are structured as a $93.2 million loan and a $3.3 million equity contribution generally provide that we will receive a preferential return of 15% of the loan amount and approximately 79% of the remaining earnings of Ernest. Ernest is required to pay us a minimum of 6% and 7% of the loan amount in years one and two, respectively, and 10% thereafter, although there are provisions in the loan agreement that are expected to result in full payment of the 15% preference when funds are sufficient. Any of the 15% in excess of the minimum that is not paid may be accrued and paid upon the occurrence of a capital or liquidity event and is payable at maturity. The loan may be prepaid without penalty at any time.

Financing of Ernest Transaction

To finance the Ernest Transaction, we completed equity and senior unsecured notes offerings in February 2012. See Notes 4 and 5 for more information on these financing activities.

2011 Activity

On January 4, 2011, we acquired the real estate of the 19-bed, 4-year old Gilbert Hospital in a suburb of Phoenix, Arizona area for $17.1 million. Gilbert Hospital is operated by affiliates of Visionary Health, LLC. We acquired this asset subject to an existing lease that expires in May 2022.

On January 31, 2011, we acquired for $23.5 million the real estate of the 60-bed Atrium Medical Center at Corinth in the Dallas area, a long-term acute care hospital that was completed in 2009 and is subject to a lease that expires in June 2024. In addition, through one of our affiliates, we invested $1.3 million to acquire approximately 19% of a joint venture arrangement with an affiliate of Vibra Healthcare, LLC ("Vibra") that will manage and has acquired a 51% interest in the operations of the facility. We also made a $5.2 million working capital loan to the joint venture. The former operators of the hospital, comprised primarily of local physicians, retained ownership of 49% of the operating entity.

On February 4, 2011, we purchased for $58 million the real estate of Bayonne Medical Center, a 6-story, 278-bed acute care hospital in the New Jersey area of metropolitan New York, and leased the facility to the operator under a 15-year lease, with six 5-year extension options. The operator is an affiliate of a private hospital operating company that acquired the hospital in 2008.

On February 9, 2011, we acquired the real estate of the 306-bed Alvarado Hospital in San Diego, California for $70 million from Prime Healthcare Services, Inc. ("Prime"). Prime is the operator of the facility and will lease the facility under a 10-year lease that provides, under certain conditions for lease extensions.

On February 14, 2011, we completed the acquisition of the Northland LTACH Hospital located in Kansas City, a 35-bed hospital that opened in April 2008 and has a lease that expires in 2028. This hospital is currently being operated by Kindred Healthcare Inc. The purchase price of this hospital was $19.5 million, which included the assumption of a $16 million mortgage loan.

As part of these acquisitions, we purchased and invested in the following assets: (dollar amounts in thousands)


	2012		2011
Land	$	—	$	16,151
Building		—		157,834
Intangible lease assets — subject to amortization (weighted average useful life of 23.1 years in 2011)		—		14,093
Net investments in direct financing leases		200,000		—
Mortgage loans		100,000		—
Other loans		93,200		5,233
Equity investments		3,300		1,268

Total	$	396,500	$	194,579

From the acquisition date, the Ernest Transaction contributed $3.9 million of revenue and $3.9 million of income (excluding related acquisition expenses) for the three months ended March 31, 2012. In addition, we incurred $3.4 million of acquisition related costs on consummated and non-consummated deals for the three months ended March 31, 2012.

The purchase price allocation attributable to the Ernest Transaction is preliminary as we are waiting on additional information to perform our final analysis. When all relevant information is obtained, resulting changes, if any, to our provisional purchase price allocation will be retrospectively adjusted to reflect new information obtained about the facts and circumstances that existed as of the respective acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date.

From the respective acquisition dates, the five hospitals acquired in 2011 contributed $3.2 million of revenue and $2.0 million of income (excluding related acquisition expenses) for the three months ended March 31, 2011, respectively. In addition, we incurred $2.0 million of acquisition related costs during the three months ended March 31, 2011.

The results of operations for each of the properties acquired are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2012 and 2011, as if each acquisition in 2012 and 2011 were consummated on the same terms at the beginning of 2011. Supplemental pro forma earnings were adjusted to exclude acquisition-related costs on consummated deals incurred in the three months ended March 31, 2012 and 2011 (dollar amounts in thousands except per share/unit data).


	For the Three Months Ended March 31,
	2012		2011
Total revenues	$	50,735	$	50,020
Net income		19,647		21,220
Net income per share/unit — diluted	$	0.14	$	0.16

Leasing Operations

Denham Springs facility

For the quarter ended March 31, 2012, there have been no significant developments to our Denham Springs facility or its operator. We have not recorded any rental revenue or reversed previously established reserves during the first quarter. At March 31, 2012, we continued to believe, based on existing collateral and the current real estate market, that the $0.7 million loan and the $4.2 million of real estate are fully recoverable; however, no assurances can be made that future reserves will not be needed.

Florence facility

On March 1, 2012, we received a certificate of occupancy for our recently constructed Florence acute care facility near Phoenix, Arizona. With this, we started recognizing rent on this facility in March 2012. During the construction period, we accrued and deferred rent based on the cost paid during the construction period. In March 2012, we began recognizing a portion of the accrued construction period rent along with interest on the unpaid amount. This accrued construction period rent will be recognized in our income statement and paid over the 25 year lease term. Land and building costs associated with this property approximates $30 million.

Ernest

We are accounting for the master lease of 12 facilities to Ernest as a DFL. The components of our net investment in DFL consisted of the following (dollars in thousands):


	As of March 31, 2012
Minimum lease payments receivable	$	901,400
Estimated residual values		200,000
Less unearned income		(901,115	)

Net investment in direct financing leases	$	200,285

Monroe facility

As of March 31, 2012, we have advanced $28.6 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana pursuant to a working capital loan agreement. In addition, as of March 31, 2012, we have $16.9 million of rent, interest and other charges owed to us by the operator, of which $5.6 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During the first quarter of 2010, we evaluated alternative strategies for the recovery of our advances and accruals and at that time determined that the future cash flows of the current tenant or related collateral would, more likely than not, result in less than a full recovery of our loan advances. Accordingly, we recorded a $12 million charge in the 2010 first quarter to recognize the estimated impairment of the working capital loan. During the third quarter of 2010, we determined that it was reasonably likely that the existing tenant would be unable to make certain lease payments that become due in future years. Accordingly, we recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. At March 31, 2012, our net investment (exclusive of the related real estate) of $33.5 million is our maximum exposure to Monroe and the amount is deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in approximately (i) $5 million in hospital patient receivables, (ii) cash balances of approximately $4 million, (iii) 100% of the membership interests of the operator/lessee and our assessment of the realizable value of our other collateral and (iv) continued improvement in operational revenue statistics compared to previous years.

We continue to evaluate possible operating strategies for the hospital. We have entered into a forbearance agreement with the operator whereby we have generally agreed, under certain conditions, not to fully exercise our rights and remedies under the lease and loan agreements during limited periods. We have not committed to the adoption of a plan to transition ownership or management of the hospital to any new operator, and there is no assurance that any such plan will be completed. Moreover, there is no assurance that any plan that we ultimately pursue will not result in additional charges for further impairment of our working capital loan. We have not recognized any interest income on the Monroe loan since it was considered impaired in the 2010 first quarter.

Loans

On March 1, 2012, pursuant to our convertible note agreement, we converted $1.7 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At March 31, 2012, $3.3 million remains outstanding on the convertible note, and we retain the option, through November 2014, to convert this remainder into 15.1% of equity interest in the operator.

Concentrations of Credit Risk

For the three months ended March 31, 2012, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 9.0% of total revenue. However, from an investment concentration perspective, Ernest represented 19.2% of our total assets at March 31, 2012.

For the three months ended March 31, 2012 and 2011, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 26.1% and 29.9%, respectively, of total revenue. However, from an investment concentration perspective, Prime represented 20.0% and 29.7% of our total assets at March 31, 2012 and 2011, respectively.

On an individual property basis, we had no investment of any single property greater than 5% of our total assets as of March 31, 2012.

From a geographic perspective, all of our properties are located in the United States with 24.0% of our total assets at March 31, 2012 located in Texas.

Debt

3 Months Ended

Mar. 31, 2012

Debt [Abstract]

Debt

4. Debt

The following is a summary of debt, net of discounts (dollar amounts in thousands):


	As of March 31, 2012				As of December 31, 2011
	Balance			Interest Rate	Balance			Interest Rate
Revolving credit facilities	$	—		Variable	$	89,600		Variable
2006 Senior Unsecured Notes		125,000		Various		125,000		Various
2011 Senior Unsecured Notes		450,000		6.875%		450,000		6.875%
2012 Senior Unsecured Notes		200,000		6.375%		—
Exchangeable senior notes:
Principal amount		11,000		9.250%		11,000		9.250%
Unamortized discount		(147	)			(180	)

		10,853				10,820
Term loans		114,372		Various		14,429		6.2000%

	$	900,225			$	689,849

As of March 31, 2012, principal payments due for our debt (which exclude the effects of any discounts recorded) are as follows:


2012	$	174
2013		11,249
2014		266
2015		283
2016		225,299
Thereafter		663,101

Total	$	900,372

To help fund the 2012 acquisitions disclosed in Note 3, on February 17, 2012, we completed a $200 million offering of senior unsecured notes ("2012 Senior Unsecured Notes"), resulting in net proceeds, after underwriting discount, of $196.5 million. These 2012 senior unsecured notes accrue interest at a fixed rate of 6.375% per year and mature on February 15, 2022. The 2012 Senior Unsecured Notes include covenants substantially consistent with our 2011 Senior Unsecured Notes.

In addition, on March 9, 2012, we closed on a $100 million senior unsecured term loan facility ("2012 Term Loan") and exercised the $70 million accordion feature on our revolving credit facility, increasing its capacity from $330 million to $400 million. The 2012 Term Loan facility has an interest rate option of (1) LIBOR plus an initial spread of 2.25% or (2) the higher of the "prime rate", federal funds rate plus 0.5%, or Eurodollar rate plus 1.0%, plus an initial spread of 1.25%. The 2012 Term Loan facility is scheduled to mature on March 9, 2016, but we have the option to extend the facility one year to March 9, 2017.

During the second quarter 2010, we entered into an interest rate swap to fix $65 million of our 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. At March 31, 2012 and December 31, 2011, the fair value of the interest rate swaps was $11.7 million and $12.2 million, respectively, which is reflected in accounts payable and accrued expenses on the condensed consolidated balance sheets.

We designated our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effect earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness in the periods; therefore, there was no income statement effect recorded during the three month periods ended March 31, 2012 or 2011. We do not expect any of the current losses included in accumulated other comprehensive loss to be reclassified into earnings in the next 12 months. At March 31, 2012 and December 31, 2011, we had $6.7 million and $6.3 million, respectively, posted as collateral, which is currently reflected in other assets on our consolidated balance sheets.

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our revolving credit facility and 2012 Term Loan limit the amount of dividends we can pay to 120% of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis starting for the fiscal quarter ending March 31, 2012. Thereafter, a similar dividend restriction exists but the percentage drops each quarter (115% for quarter ending June 30, 2012) until reaching 95% at June 30, 2013. The indenture governing our 2011 and 2012 Senior Unsecured Notes also limits the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our 2011 and 2012 Senior Unsecured Notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.

In addition to these restrictions, the credit facility and 2012 Term Loan contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and borrowing base interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At March 31, 2012, we were in compliance with all such financial and operating covenants.

Common Stock/Partner's Capital	3 Months Ended
Common Stock/Partner's Capital	Mar. 31, 2012
Common Stock/Partner's Capital [Abstract]
Common Stock/Partner's Capital	5. Common Stock/Partner's Capital Medical Properties Trust, Inc. To help fund the 2012 acquisitions disclosed in Note 3, on February 7, 2012, we completed an offering of 23,575,000 shares of our common stock (including 3,075,000 shares sold pursuant to the exercise in full of the underwriters' overallotment option) at a price of $9.75 per share, resulting in net proceeds (after underwriting discount) of $220.2 million. MPT Operating Partnership, L.P. At March 31, 2012, the Company has a 99.8% ownership interest in Operating Partnership with the remainder owned by three other partners, two of which are employees and one of which is a director. During the quarter ended March 31, 2012, the partnership issued 23,575,000 units in direct response to the common stock offering by Medical Properties Trust, Inc.

Stock Awards	3 Months Ended
Stock Awards	Mar. 31, 2012
Stock Awards [Abstract]
Stock Awards	6. Stock Awards Our Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the "Equity Incentive Plan") authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,441,180 shares of common stock for awards under the Equity Incentive Plan for which 1,438,541 shares remain available for future stock awards as of March 31, 2012. We awarded the following during 2012 and 2011: Time-based awards—We granted 275,464 and 292,803 shares in 2012 and 2011, respectively, of time-based restricted stock to management, independent directors, and certain employees (2011 only). These awards vest quarterly based on service, over three years, in equal amounts. Performance-based awards—Our management team and certain employees (2011 only) were awarded 252,566 and 253,655 performance based awards in 2012 and 2011, respectively. These awards vest ratably over a three year period based on the achievement of certain total shareholder return measures, with a carry-back and carryforward provision through December 31, 2015 (for the 2011 awards) and December 31, 2016 (for the 2012 awards). Dividends on these awards are paid only upon achievement of the performance measures. Multi-year Performance-based awards—We awarded 649,793 and 600,000 shares in 2012 and 2011, respectively, of multi-year performance-based awards to management and certain employees. These shares are subject to three-year cumulative performance hurdles based on total shareholder return. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Fair Value Of Financial Instruments [Abstract]

Fair Value Of Financial Instruments

3 Months Ended

Mar. 31, 2012

Fair Value Of Financial Instruments

7. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our loans, interest, and other receivables by discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes based on quotes from securities dealers and market makers. We estimate the fair value of our senior notes, revolving credit facilities, and term loans based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

The following table summarizes fair value information for our financial instruments (dollar amounts in thousands):


	March 31, 2012						December 31, 2011
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables (2)	$	33,650		$	26,406		$	29,862		$	22,866
Loans (2)		430,207			433,033			239,839			243,272
Debt, net (2)		(900,225	)		(909,159	)		(689,849	)		(688,032	)

(2)

Level II: Fair value based on quoted prices for similar or identical instruments in active or inactive markets, respectively, or calculated utilizing model-derived valuations in which significant inputs or value drivers are observable in active markets.

As discussed in Note 2, our equity interest in Ernest and related loans are being measured at fair value on a recurring basis. At March 31, 2012, these amounts were as follows (in thousands):


Asset Type	Fair Value	Cost	Asset Type Classification
Mortgage loans	$100,000	$100,000	Mortgage loans
Acquisition loan	93,200	93,200	Other loans
Equity investments	3,300	3,300	Other assets

	$196,500	$196,500

Our mortgage and acquisition loans are recorded at fair value based on Level 2 observable market assumptions, which means they are calculated utilizing model-derived valuations in which significant inputs or value drivers (such as market interest rates are observable in active markets. Our equity investments is recorded at fair value based on Level III assumptions, which means it is calculated using valuation techniques in which one or more significant inputs or value drivers are unobservable. For the quarter ended March 31, 2012 and because the Ernest Transaction was completed and accounted for at fair value near quarter-end, we had no gains/losses from fair value adjustments in our income statement. We recorded approximately $2.0 million of interest on these loans during the quarter.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44A, 44B
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15C, 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15A
-Subparagraph a-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15B
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 3, 10, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32, 33, 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 17-22, 27, 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13504-108611

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

Discontinued Operations

3 Months Ended

Mar. 31, 2012

Discontinued Operations [Abstract]

Discontinued Operations

8. Discontinued Operations

On December 30, 2011, we sold MountainView Regional Rehabilitation Hospital in Morgantown, West Virginia to HealthSouth Corporation for $21.1 million, resulting in a gain of $2.3 million. On December 30, 2011, we also sold Sherman Oaks Hospital in Sherman Oaks, California to Prime for $20.0 million, resulting in a gain of $3.1 million. Due to this sale, we wrote-off $1.2 million in straight-line rent receivables.

The following table presents the results of discontinued operations, which include the revenue and expenses of the two previously-owned facilities noted above, for the three months ended March 31, 2012 and 2011 (dollar amounts in thousands except per share/unit amounts):


	For the Three Months Ended March 31,
	2012		2011
Revenues	$	121	$	1,351
Gain on sale		—		5
Income (loss)		121		1,172
Earnings per share/unit — diluted	$	—	$	0.01

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43-48
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6390789&loc=d3e2443-110228

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Earnings Per Share/Common Unit [Abstract]

Earnings Per Share/Common Unit

3 Months Ended

Mar. 31, 2012

Earnings Per Share/Common Unit

9. Earnings Per Share/Common Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (amounts in thousands):


	For the Three Months Ended March 31,
	2012			2011
Numerator:
Income from continuing operations	$	10,485		$	9,652
Non-controlling interests' share in continuing operations		(42	)		(44	)
Participating securities' share in earnings		(252	)		(316	)

Income from continuing operations, less participating securities' share in earnings		10,191			9,292
Income from discontinued operations attributable to MPT common stockholders		121			1,172

Net income, less participating securities' share in earnings	$	10,312		$	10,464

Denominator
Basic weighted-average common shares		124,906			110,400
Dilutive share options		—			8

Dilutive weighted-average common shares		124,906			110,408

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (amounts in thousands):


	For the Three Months Ended March 31,
	2012			2011
Numerator:
Income from continuing operations	$	10,485		$	9,668
Non-controlling interests' share in continuing operations		(42	)		(44	)
Participating securities' share in earnings		(252	)		(316	)

Income from continuing operations, less participating securities' share in earnings		10,191			9,308
Income from discontinued operations attributable to MPT Operating Partnership partners		121			1,172

Net income, less participating securities' share in earnings	$	10,312		$	10,480

Denominator
Basic weighted-average units		124,906			110,400
Dilutive options		—			8

Dilutive weighted-average units		124,906			110,408

For the three months ended March 31, 2012 and 2011, 0.1 million of options were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive. Shares/units that may be issued in the future in accordance with our exchangeable senior notes were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive.

Contingencies	3 Months Ended
Contingencies	Mar. 31, 2012
Contingencies [Abstract]
Contingencies	10. Contingencies We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

The entire disclosure for commitments and contingencies.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Condensed Consolidating Financial Information [Abstract]

Condensed Consolidating Financial Information

3 Months Ended

Mar. 31, 2012

Condensed Consolidating Financial Information

11. Condensed Consolidating Financial Information

The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. ("Parent" and a guarantor to our 2011 and 2012 Senior Unsecured Notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation ("Subsidiary Issuer"), (c) on a combined basis, the guarantors of our 2011 and 2012 Senior Unsecured Notes ("Subsidiary Guarantors"), and (d) on a combined basis, the non-guarantor subsidiaries ("Non-Guarantor Subsidiaries"). Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is joint and several, and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent's ability to obtain funds from its subsidiaries by dividend or loan.

The guarantees by the Subsidiary Guarantors may be released and discharged upon: (1) any sale, exchange or transfer of all of the capital stock of a Subsidiary Guarantor; (2) the merger or consolidation of a Subsidiary Guarantor with a Subsidiary Issuer or any other Subsidiary Guarantor; (3) the proper designation of any Subsidiary Guarantor by the Subsidiary Issuers as "unrestricted" for covenant purposes under the indenture governing the 2011 and 2012 Senior Unsecured Notes; (4) the legal defeasance or covenant defeasance or satisfaction and discharge of the indenture; (5) a liquidation or dissolution of a Subsidiary Guarantor permitted under the indenture governing the 2011 and 2012 Senior Unsecured Notes; or (6) the release or discharge of the Subsidiary Guarantor from its guarantee obligations under our revolving credit facility.

Subsequent to December 31, 2011, one of our subsidiaries was re-designated as a guarantor of our 2011 and 2012 Senior Unsecured Notes (subsidiary was a non-guarantor during 2011). With this re-designation, we have restated the 2011 condensed consolidating financial information below to reflect this change.

Condensed Consolidated Balance Sheet

March 31, 2012

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	708	$	1,153,464		$	128,201		$	—		$	1,282,373
Mortgage loans		—		—		165,000			100,000			—			265,000
Net investment in direct financing leases		—		—		—			200,285			—			200,285

Gross investment in real estate assets		—		708		1,318,464			428,486			—			1,747,658
Accumulated depreciation and amortization		—		—		(99,789	)		(12,695	)		—			(112,484	)

Net investment in real estate assets				708		1,218,675			415,791			—			1,635,174
Cash & cash equivalents		—		124,850		1,564			86			—			126,500
Interest and rent receivable		—		412		24,562			8,676			—			33,650
Straight-line rent receivable		—		—		25,050			10,443			—			35,493
Other loans		—		177		—			165,030			—			165,207
Net intercompany receivable (payable)		27,121		1,275,634		(864,229	)		(438,526	)		—			—
Investment in subsidiaries		1,035,137		519,209		42,969			—			(1,597,315	)		—
Other assets		—		32,868		1,606			17,964			—			52,438

Total Assets	$	1,062,258	$	1,953,858	$	450,197		$	179,464		$	(1,597,315	)	$	2,048,462

Liabilities and Equity
Liabilities
Debt, net	$	—		885,853	$	—		$	14,372		$	—		$	900,225
Accounts payable and accrued expenses		27,511		32,317		1,862			588			—			62,278
Deferred revenue		—		551		16,782			5,211			—			22,544
Lease deposits and other obligations to tenants		—		—		28,028			640			—			28,668

Total liabilities		27,511		918,721		46,672			20,811			—			1,013,715
Total Medical Properties Trust Inc. stockholder's equity		1,034,747		1,035,137		403,525			158,653			(1,597,315	)		1,034,747

Non-controlling interests		—		—		—			—			—			—

Total equity		1,034,747		1,035,137		403,525			158,653			(1,597,315	)		1,034,747

Total Liabilities and Equity	$	1,062,258	$	1,953,858	$	450,197		$	179,464		$	(1,597,315	)	$	2,048,462

Condensed Consolidated Statements of Income

For the Three Months Ended March 31, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	28,635	$	5,990		$	(2,460	)	$	32,165
Straight-line rent		—			—			993		456			—			1,449
Income from direct financing leases		—			—			1,653		1,835			(1,653	)		1,835
Interest and fee income		—			2,944			5,035		3,586			(3,623	)		7,942

Total revenues		—			2,944			36,316		11,867			(7,736	)		43,391
Expenses
Real estate depreciation and amortization		—			—			7,966		780			—			8,746
Property-related		—			131			200		4,114			(4,114	)		331
General and administrative		—			6,962			—		630			—			7,592
Acquisition expenses		—			3,425			—		—			—			3,425

Total operating expenses		—			10,518			8,166		5,524			(4,114	)		20,094

Operating income (expense)		—			(7,574	)		28,150		6,343			(3,622	)		23,297
Other income (expense)
Interest income (expense) and other		—			(14	)		—		(2	)		—			(16	)
Interest income (expense)		—			(12,788	)		391		(4,021	)		3,622			(12,796	)

Net other income (expense)		—			(12,802	)		391		(4,023	)		3,622			(12,812	)

Income (loss) from continuing operations		—			(20,376	)		28,541		2,320			—			10,485
Income from discontinued operations		—			—			—		121			—			121
Equity in earnings of consolidated subsidiaries net of income taxes		10,606			30,982			1,121		—			(42,709	)		—

Net income (loss)		10,606			10,606			29,662		2,441			(42,709	)		10,606
Net income attributable to non-controlling interests		(42	)		(42	)		—		—			42			(42	)

Net income (loss) attributable to MPT common stockholders	$	10,564		$	10,564		$	29,662	$	2,441		$	(42,667	)	$	10,564

Condensed Consolidated Statements of Cash Flows

For the Three Months Ended March 31, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	395		$	(11,062	)	$	32,317		$	1,702		$	—		$	23,352
Investing Activities
Real estate acquired		—			—			(671	)		—			—			(671	)
Principal received on loans receivable		—			—			—			1,184			—			1,184
Investments in and advances to subsidiaries		(198,243	)		(406,447	)		174,658			232,184			197,848			—
Investments in loans receivable direct financing leases, and other investments		—			—			(200,000	)		(196,500	)		—			(396,500	)
Construction in progress and other		—			(490	)		(6,304	)		1,372			—			(5,422	)

Net cash provided by (used in) investing activities		(198,243	)		(406,937	)		(32,317	)		38,240			197,848			(401,409	)
Financing Activities
Revolving credit facilities, net		—			(50,000	)		—			(39,600	)		—			(89,600	)
Additions to term debt		—			300,000			—			—			—			300,000
Payments of term debt		—			—			—			(58	)		—			(58	)
Distributions paid		(22,345	)		(22,412	)		—			—			22,345			(22,412	)
Sale of common stock, net		220,193			220,193			—			—			(220,193	)		220,193
Lease deposits and other obligations to tenants		—			—			155			(265	)		—			(110	)
Debt issuance costs paid and other financing activities		—			(6,162	)		—			(20	)		—			(6,182	)

Net cash provided by financing activities		197,848			441,619			155			(39,943	)		(197,848	)		401,831

Increase (decrease) in cash and cash equivalents for period		—			23,620			155			(1	)		—			23,774
Cash and cash equivalents at beginning of period		—			101,230			1,409			87			—			102,726

Cash and cash equivalents at end of period	$	—		$	124,850		$	1,564		$	86		$	—		$	126,500

Condensed Consolidated Balance Sheets

December 31, 2011

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	37	$	1,147,161		$	128,201		$	—		$	1,275,399
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		37		1,312,161			128,201			—			1,440,399
Accumulated depreciation and amortization		—		—		(91,822	)		(11,915	)		—			(103,737	)

Net investment in real estate assets		—		37		1,220,339			116,286			—			1,336,662
Cash & cash equivalents		—		101,230		1,409			87			—			102,726
Interest and rent receivables		—		399		22,529			6,934			—			29,862
Straight-line rent receivables		—		—		24,005			9,988			—			33,993
Other loans		—		177		—			74,662			—			74,839
Net intercompany receivable (payable)		21,955		872,382		(889,585	)		(4,752	)		—			—
Investment in subsidiaries		829,205		489,858		43,008			—			(1,362,071	)		—
Other assets		—		27,284		1,727			14,781			—			43,792

Total Assets	$	851,160	$	1,491,367	$	423,432		$	217,986		$	(1,362,071	)	$	1,621,874

Liabilities and Equity
Liabilities
Debt, net	$	—	$	635,820	$	—		$	54,029		$	—		$	689,849
Accounts payable and accrued expenses		22,345		25,783		2,576			421			—			51,125
Deferred revenue		—		559		17,488			5,260			—			23,307
Lease deposits and other obligations to tenants		—		—		27,874			904			—			28,778

Total liabilities		22,345		662,162		47,938			60,614			—			793,059

Total Medical Properties Trust Inc. stockholder's equity		828,815		829,205		375,494			157,372			(1,362,071	)		828,815

Non-controlling interests		—		—		—			—			—			—

Total equity		828,815		829,205		375,494			157,372			(1,362,071	)		828,815

Total Liabilities and Equity	$	851,160	$	1,491,367	$	423,432		$	217,986		$	(1,362,071	)	$	1,621,874

Condensed Consolidated Statements of Income

For the Three Months Ended March 31, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	24,179		$	3,508		$	(332	)	$	27,355
Straight-line rent		—			—			1,247			463			—			1,710
Interest and fee income		—			1,397			4,447			945			(1,507	)		5,282

Total revenues		—			1,397			29,873			4,916			(1,839	)		34,347
Expenses
Real estate depreciation and amortization		—			—			6,833			737			—			7,570
Property-related		—			35			(72	)		427			(332	)		58
General and administrative		16			6,005			—			853			—			6,874
Acquisition expenses		—			1,625			—			415			—			2,040

Total operating expenses		16			7,665			6,761			2,432			(332	)		16,542

Operating income (loss)		(16	)		(6,268	)		23,112			2,484			(1,507	)		17,805
Other income (expense)
Interest income and other		—			(24	)		8			2			—			(14	)
Interest expense		—			(7,968	)		(27	)		(1,651	)		1,507			(8,139	)

Net other income (expense)		—			(7,992	)		(19	)		(1,649	)		1,507			(8,153	)

Income (loss) from continuing operations		(16	)		(14,260	)		23,093			835			—			9,652
Income (loss) from discontinued operations		—			—			—			1,172			—			1,172
Equity in earnings of consolidated subsidiaries net of income taxes		10,840			25,100			1,078			—			(37,018	)		—

Net income (loss)		10,824			10,840			24,171			2,007			(37,018	)		10,824
Net income (loss) attributable to non-controlling interests		(44	)		(44	)		—			—			44			(44	)

Net income attributable to MPT common stockholders	$	10,780		$	10,796		$	24,171		$	2,007		$	(36,974	)	$	10,780

Condensed Consolidated Statements of Cash Flows

For the Three Months Ended March 31, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(49	)	$	(8,847	)	$	19,492		$	8,690		$	—		$	19,286
Investing Activities
Real estate acquired		—			—			(168,589	)		(4,897	)		—			(173,486	)
Principal received on loans receivable		—			—			—			580			—			580
Investments in and advances to subsidiaries		22,366			(109,826	)		147,823			(38,046	)		(22,317	)		—
Investments in loans receivable and other investments		—			—			—			(5,463	)		—			(5,463	)
Construction in progress and other		—			—			(3,064	)		(1,583	)		—			(4,647	)

Net cash provided by (used in) investing activities		22,366			(109,826	)		(23,830	)		(49,409	)		(22,317	)		(183,016	)
Financing Activities
Revolving credit facilities, net		—			58,000			—			40,400			—			98,400
Payments of term debt		—			(6,851	)		(70	)		(24	)		—			(6,945	)
Distributions paid		(22,317	)		(22,374	)		—			—			22,317			(22,374	)
Lease deposits and other obligations to tenants		—			—			3,032			580			—			3,612
Debt issuance costs paid and other financing activities		—			(225	)		—			(136	)		—			(361	)

Net cash provided by financing activities		(22,317	)		28,550			2,962			40,820			22,317			72,332

Increase in cash and cash equivalents for period		—			(90,123	)		(1,376	)		101			—			(91,398	)
Cash and cash equivalents at beginning of period		—			96,822			1,387			199			—			98,408

Cash and cash equivalents at end of period	$	—		$	6,699		$	11		$	300		$	—		$	7,010

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies (Policy)

3 Months Ended

Mar. 31, 2012

Unaudited Interim Condensed Consolidated Financial Statements

Variable Interest Entities

Variable Interest Entities


VIE Type	Maximum Loss Exposure(1)	Asset Type Classification	Carrying Amount(2)
Loans, net	$263,977	Mortgage and other loans	$231,568
Equity investments	$ 13,220	Other assets	$ 2,751

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 140
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 5, 6, 16-19
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 20
-Subparagraph a(2)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 96-16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 97-2
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 3A
-Section 02, 03

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph k
-Article 1

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 40
-Section 45
-URI http://asc.fasb.org/section&trid=2197723

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=6959686&loc=d3e355033-122828

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2196966

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6382870&loc=d3e33801-111570

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 325
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2197087

Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=6970148&loc=d3e5728-111685

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6759159-111685

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 22B
-Subparagraph a

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 22E
-Subparagraph a

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 24
-Subparagraph e

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 2AA
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6759068-111685

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2012

Schedule Of Carrying Value Of Variable Interest Entities


VIE Type	Maximum Loss Exposure(1)	Asset Type Classification	Carrying Amount(2)
Loans, net	$263,977	Mortgage and other loans	$231,568
Equity investments	$ 13,220	Other assets	$ 2,751

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph g
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 2, 14, 15, 16, 23, 24, 25, 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 140
-Paragraph 35
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6970148&loc=d3e5728-111685

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6970148&loc=d3e5710-111685

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6970148&loc=d3e5747-111685

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Variable Interest Entity
-URI http://asc.fasb.org/extlink&oid=6528138

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph C4
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 22B

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 22E

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 23A

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 24

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6759159-111685

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228884-111685

Real Estate And Lending Activities [Abstract]

Real Estate And Lending Activities (Tables)

3 Months Ended

Mar. 31, 2012

List Of Assets Purchased As Part Of Acquisitions


	2012		2011
Land	$	—	$	16,151
Building		—		157,834
Intangible lease assets — subject to amortization (weighted average useful life of 23.1 years in 2011)		—		14,093
Net investments in direct financing leases		200,000		—
Mortgage loans		100,000		—
Other loans		93,200		5,233
Equity investments		3,300		1,268

Total	$	396,500	$	194,579

Unaudited Pro Forma Consolidated Financial Data


	For the Three Months Ended March 31,
	2012		2011
Total revenues	$	50,735	$	50,020
Net income		19,647		21,220
Net income per share/unit — diluted	$	0.14	$	0.16

Schedule Of Components Of Net Investments In DFL


	As of March 31, 2012
Minimum lease payments receivable	$	901,400
Estimated residual values		200,000
Less unearned income		(901,115	)

Net investment in direct financing leases	$	200,285

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Appendix F
-Paragraph F4
-Subparagraph e

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6972119&loc=d3e1392-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6972119&loc=d3e1486-128463

Principal Payments Due For Debt

Debt (Tables)

3 Months Ended

Mar. 31, 2012

Debt [Abstract]

Summary Of Debt


	As of March 31, 2012				As of December 31, 2011
	Balance			Interest Rate	Balance			Interest Rate
Revolving credit facilities	$	—		Variable	$	89,600		Variable
2006 Senior Unsecured Notes		125,000		Various		125,000		Various
2011 Senior Unsecured Notes		450,000		6.875%		450,000		6.875%
2012 Senior Unsecured Notes		200,000		6.375%		—
Exchangeable senior notes:
Principal amount		11,000		9.250%		11,000		9.250%
Unamortized discount		(147	)			(180	)

		10,853				10,820
Term loans		114,372		Various		14,429		6.2000%

	$	900,225			$	689,849


2012	$	174
2013		11,249
2014		266
2015		283
2016		225,299
Thereafter		663,101

Total	$	900,372

Fair Value Of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2012

Fair Value Of Financial Instruments [Abstract]

Summary Of Fair Value Information Of Financial Instruments


	March 31, 2012						December 31, 2011
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables (2)	$	33,650		$	26,406		$	29,862		$	22,866
Loans (2)		430,207			433,033			239,839			243,272
Debt, net (2)		(900,225	)		(909,159	)		(689,849	)		(688,032	)

(2)

Schedule Of Equity Interest


Asset Type	Fair Value	Cost	Asset Type Classification
Mortgage loans	$100,000	$100,000	Mortgage loans
Acquisition loan	93,200	93,200	Other loans
Equity investments	3,300	3,300	Other assets

	$196,500	$196,500

Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such certain disclosures about the financial instruments, assets, and liabilities include: (1) the fair value of the required items together with their carrying amounts (as appropriate) and (2) the methodology and assumptions used in developing such estimates of fair value.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 14
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15
-Subparagraph b-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32
-Subparagraph a, c(1), c(2), c(3), d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 18
-Subparagraph c(2), d, e, f
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 19
-Subparagraph a, b, c(1), d(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13467-108611

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13476-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6447952&loc=d3e13220-108610

Schedule Of Discontinued Operations

Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2012

Discontinued Operations [Abstract]


	For the Three Months Ended March 31,
	2012		2011
Revenues	$	121	$	1,351
Gain on sale		—		5
Income (loss)		121		1,172
Earnings per share/unit — diluted	$	—	$	0.01

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]

Earnings Per Share/Common Unit (Tables)

3 Months Ended

Mar. 31, 2012

Calculation Of Earnings Per Share


	For the Three Months Ended March 31,
	2012			2011
Numerator:
Income from continuing operations	$	10,485		$	9,652
Non-controlling interests' share in continuing operations		(42	)		(44	)
Participating securities' share in earnings		(252	)		(316	)

Income from continuing operations, less participating securities' share in earnings		10,191			9,292
Income from discontinued operations attributable to MPT common stockholders		121			1,172

Net income, less participating securities' share in earnings	$	10,312		$	10,464

Denominator
Basic weighted-average common shares		124,906			110,400
Dilutive share options		—			8

Dilutive weighted-average common shares		124,906			110,408

MPT Operating Partnership, L.P. [Member]

Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]

Calculation Of Earnings Per Share


	For the Three Months Ended March 31,
	2012			2011
Numerator:
Income from continuing operations	$	10,485		$	9,668
Non-controlling interests' share in continuing operations		(42	)		(44	)
Participating securities' share in earnings		(252	)		(316	)

Income from continuing operations, less participating securities' share in earnings		10,191			9,308
Income from discontinued operations attributable to MPT Operating Partnership partners		121			1,172

Net income, less participating securities' share in earnings	$	10,312		$	10,480

Denominator
Basic weighted-average units		124,906			110,400
Dilutive options		—			8

Dilutive weighted-average units		124,906			110,408

Condensed Consolidating Financial Information (Tables)

3 Months Ended

Mar. 31, 2012

Condensed Consolidating Financial Information [Abstract]

Summary Of Condensed Consolidated Balance Sheet

Condensed Consolidated Balance Sheet

March 31, 2012

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	708	$	1,153,464		$	128,201		$	—		$	1,282,373
Mortgage loans		—		—		165,000			100,000			—			265,000
Net investment in direct financing leases		—		—		—			200,285			—			200,285

Gross investment in real estate assets		—		708		1,318,464			428,486			—			1,747,658
Accumulated depreciation and amortization		—		—		(99,789	)		(12,695	)		—			(112,484	)

Net investment in real estate assets				708		1,218,675			415,791			—			1,635,174
Cash & cash equivalents		—		124,850		1,564			86			—			126,500
Interest and rent receivable		—		412		24,562			8,676			—			33,650
Straight-line rent receivable		—		—		25,050			10,443			—			35,493
Other loans		—		177		—			165,030			—			165,207
Net intercompany receivable (payable)		27,121		1,275,634		(864,229	)		(438,526	)		—			—
Investment in subsidiaries		1,035,137		519,209		42,969			—			(1,597,315	)		—
Other assets		—		32,868		1,606			17,964			—			52,438

Total Assets	$	1,062,258	$	1,953,858	$	450,197		$	179,464		$	(1,597,315	)	$	2,048,462

Liabilities and Equity
Liabilities
Debt, net	$	—		885,853	$	—		$	14,372		$	—		$	900,225
Accounts payable and accrued expenses		27,511		32,317		1,862			588			—			62,278
Deferred revenue		—		551		16,782			5,211			—			22,544
Lease deposits and other obligations to tenants		—		—		28,028			640			—			28,668

Total liabilities		27,511		918,721		46,672			20,811			—			1,013,715
Total Medical Properties Trust Inc. stockholder's equity		1,034,747		1,035,137		403,525			158,653			(1,597,315	)		1,034,747

Non-controlling interests		—		—		—			—			—			—

Total equity		1,034,747		1,035,137		403,525			158,653			(1,597,315	)		1,034,747

Total Liabilities and Equity	$	1,062,258	$	1,953,858	$	450,197		$	179,464		$	(1,597,315	)	$	2,048,462

Condensed Consolidated Balance Sheets

December 31, 2011

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	37	$	1,147,161		$	128,201		$	—		$	1,275,399
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		37		1,312,161			128,201			—			1,440,399
Accumulated depreciation and amortization		—		—		(91,822	)		(11,915	)		—			(103,737	)

Net investment in real estate assets		—		37		1,220,339			116,286			—			1,336,662
Cash & cash equivalents		—		101,230		1,409			87			—			102,726
Interest and rent receivables		—		399		22,529			6,934			—			29,862
Straight-line rent receivables		—		—		24,005			9,988			—			33,993
Other loans		—		177		—			74,662			—			74,839
Net intercompany receivable (payable)		21,955		872,382		(889,585	)		(4,752	)		—			—
Investment in subsidiaries		829,205		489,858		43,008			—			(1,362,071	)		—
Other assets		—		27,284		1,727			14,781			—			43,792

Total Assets	$	851,160	$	1,491,367	$	423,432		$	217,986		$	(1,362,071	)	$	1,621,874

Liabilities and Equity
Liabilities
Debt, net	$	—	$	635,820	$	—		$	54,029		$	—		$	689,849
Accounts payable and accrued expenses		22,345		25,783		2,576			421			—			51,125
Deferred revenue		—		559		17,488			5,260			—			23,307
Lease deposits and other obligations to tenants		—		—		27,874			904			—			28,778

Total liabilities		22,345		662,162		47,938			60,614			—			793,059

Total Medical Properties Trust Inc. stockholder's equity		828,815		829,205		375,494			157,372			(1,362,071	)		828,815

Non-controlling interests		—		—		—			—			—			—

Total equity		828,815		829,205		375,494			157,372			(1,362,071	)		828,815

Total Liabilities and Equity	$	851,160	$	1,491,367	$	423,432		$	217,986		$	(1,362,071	)	$	1,621,874

Summary Of Condensed Consolidated Statements Of Income

Condensed Consolidated Statements of Income

For the Three Months Ended March 31, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	28,635	$	5,990		$	(2,460	)	$	32,165
Straight-line rent		—			—			993		456			—			1,449
Income from direct financing leases		—			—			1,653		1,835			(1,653	)		1,835
Interest and fee income		—			2,944			5,035		3,586			(3,623	)		7,942

Total revenues		—			2,944			36,316		11,867			(7,736	)		43,391
Expenses
Real estate depreciation and amortization		—			—			7,966		780			—			8,746
Property-related		—			131			200		4,114			(4,114	)		331
General and administrative		—			6,962			—		630			—			7,592
Acquisition expenses		—			3,425			—		—			—			3,425

Total operating expenses		—			10,518			8,166		5,524			(4,114	)		20,094

Operating income (expense)		—			(7,574	)		28,150		6,343			(3,622	)		23,297
Other income (expense)
Interest income (expense) and other		—			(14	)		—		(2	)		—			(16	)
Interest income (expense)		—			(12,788	)		391		(4,021	)		3,622			(12,796	)

Net other income (expense)		—			(12,802	)		391		(4,023	)		3,622			(12,812	)

Income (loss) from continuing operations		—			(20,376	)		28,541		2,320			—			10,485
Income from discontinued operations		—			—			—		121			—			121
Equity in earnings of consolidated subsidiaries net of income taxes		10,606			30,982			1,121		—			(42,709	)		—

Net income (loss)		10,606			10,606			29,662		2,441			(42,709	)		10,606
Net income attributable to non-controlling interests		(42	)		(42	)		—		—			42			(42	)

Net income (loss) attributable to MPT common stockholders	$	10,564		$	10,564		$	29,662	$	2,441		$	(42,667	)	$	10,564

Condensed Consolidated Statements of Income

For the Three Months Ended March 31, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	24,179		$	3,508		$	(332	)	$	27,355
Straight-line rent		—			—			1,247			463			—			1,710
Interest and fee income		—			1,397			4,447			945			(1,507	)		5,282

Total revenues		—			1,397			29,873			4,916			(1,839	)		34,347
Expenses
Real estate depreciation and amortization		—			—			6,833			737			—			7,570
Property-related		—			35			(72	)		427			(332	)		58
General and administrative		16			6,005			—			853			—			6,874
Acquisition expenses		—			1,625			—			415			—			2,040

Total operating expenses		16			7,665			6,761			2,432			(332	)		16,542

Operating income (loss)		(16	)		(6,268	)		23,112			2,484			(1,507	)		17,805
Other income (expense)
Interest income and other		—			(24	)		8			2			—			(14	)
Interest expense		—			(7,968	)		(27	)		(1,651	)		1,507			(8,139	)

Net other income (expense)		—			(7,992	)		(19	)		(1,649	)		1,507			(8,153	)

Income (loss) from continuing operations		(16	)		(14,260	)		23,093			835			—			9,652
Income (loss) from discontinued operations		—			—			—			1,172			—			1,172
Equity in earnings of consolidated subsidiaries net of income taxes		10,840			25,100			1,078			—			(37,018	)		—

Net income (loss)		10,824			10,840			24,171			2,007			(37,018	)		10,824
Net income (loss) attributable to non-controlling interests		(44	)		(44	)		—			—			44			(44	)

Net income attributable to MPT common stockholders	$	10,780		$	10,796		$	24,171		$	2,007		$	(36,974	)	$	10,780

Summary Of Condensed Consolidated Statements Of Cash Flows

Condensed Consolidated Statements of Cash Flows

For the Three Months Ended March 31, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	395		$	(11,062	)	$	32,317		$	1,702		$	—		$	23,352
Investing Activities
Real estate acquired		—			—			(671	)		—			—			(671	)
Principal received on loans receivable		—			—			—			1,184			—			1,184
Investments in and advances to subsidiaries		(198,243	)		(406,447	)		174,658			232,184			197,848			—
Investments in loans receivable direct financing leases, and other investments		—			—			(200,000	)		(196,500	)		—			(396,500	)
Construction in progress and other		—			(490	)		(6,304	)		1,372			—			(5,422	)

Net cash provided by (used in) investing activities		(198,243	)		(406,937	)		(32,317	)		38,240			197,848			(401,409	)
Financing Activities
Revolving credit facilities, net		—			(50,000	)		—			(39,600	)		—			(89,600	)
Additions to term debt		—			300,000			—			—			—			300,000
Payments of term debt		—			—			—			(58	)		—			(58	)
Distributions paid		(22,345	)		(22,412	)		—			—			22,345			(22,412	)
Sale of common stock, net		220,193			220,193			—			—			(220,193	)		220,193
Lease deposits and other obligations to tenants		—			—			155			(265	)		—			(110	)
Debt issuance costs paid and other financing activities		—			(6,162	)		—			(20	)		—			(6,182	)

Net cash provided by financing activities		197,848			441,619			155			(39,943	)		(197,848	)		401,831

Increase (decrease) in cash and cash equivalents for period		—			23,620			155			(1	)		—			23,774
Cash and cash equivalents at beginning of period		—			101,230			1,409			87			—			102,726

Cash and cash equivalents at end of period	$	—		$	124,850		$	1,564		$	86		$	—		$	126,500

Condensed Consolidated Statements of Cash Flows

For the Three Months Ended March 31, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(49	)	$	(8,847	)	$	19,492		$	8,690		$	—		$	19,286
Investing Activities
Real estate acquired		—			—			(168,589	)		(4,897	)		—			(173,486	)
Principal received on loans receivable		—			—			—			580			—			580
Investments in and advances to subsidiaries		22,366			(109,826	)		147,823			(38,046	)		(22,317	)		—
Investments in loans receivable and other investments		—			—			—			(5,463	)		—			(5,463	)
Construction in progress and other		—			—			(3,064	)		(1,583	)		—			(4,647	)

Net cash provided by (used in) investing activities		22,366			(109,826	)		(23,830	)		(49,409	)		(22,317	)		(183,016	)
Financing Activities
Revolving credit facilities, net		—			58,000			—			40,400			—			98,400
Payments of term debt		—			(6,851	)		(70	)		(24	)		—			(6,945	)
Distributions paid		(22,317	)		(22,374	)		—			—			22,317			(22,374	)
Lease deposits and other obligations to tenants		—			—			3,032			580			—			3,612
Debt issuance costs paid and other financing activities		—			(225	)		—			(136	)		—			(361	)

Net cash provided by financing activities		(22,317	)		28,550			2,962			40,820			22,317			72,332

Increase in cash and cash equivalents for period		—			(90,123	)		(1,376	)		101			—			(91,398	)
Cash and cash equivalents at beginning of period		—			96,822			1,387			199			—			98,408

Cash and cash equivalents at end of period	$	—		$	6,699		$	11		$	300		$	—		$	7,010

Summary Of Significant Accounting Policies (Schedule Of Carrying Value Of Variable Interest Entities) (Details)
$ in Thousands

Mar. 31, 2012

USD ($)

Loans, Net [Member]

Equity Investments [Member]

Maximum Loss Exposure

$ 263,977

^[1]

Mortgage And Other Loans [Member]

Maximum Loss Exposure

13,220

^[1]

Carrying Amount

231,568

^[2]

Other Assets [Member]

Carrying Amount

$ 2,751

^[2]

[1]

[2]

Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

Real Estate And Lending Activities (Narrative) (Details) $ in Thousands					3 Months Ended				9 Months Ended	12 Months Ended
	Mar. 01, 2012 USD ($)	Feb. 14, 2011 USD ($)	Jan. 31, 2011 USD ($)	Jan. 04, 2011 USD ($) yr	Mar. 31, 2012 USD ($) yr	Sep. 30, 2011 USD ($)	Mar. 31, 2011 USD ($)	Mar. 31, 2010 USD ($)	Sep. 30, 2011	Dec. 31, 2011	Feb. 29, 2012 USD ($)	Feb. 09, 2011 USD ($)	Feb. 04, 2011 USD ($)
Real Estate And Lending Activities [Line Items]
Aggregate purchase price					$ 200,000
Term of lease, years					20
Number of lease extension options in current lease contract					3
Term of lease extension, years					5
Percentage of rental rate					9.00%
Loan secured by mortgage interest					$ 100,000
Coupon payable in cash, year one					6.00%
Coupon payable in cash, year two					7.00%
Coupon payable in cash in, thereafter					10.00%
Income contributed by the acquired entity					$ 19,647		$ 21,220
Promissory note					$ 700
Amount of convertible note converted into equity interest	$ 1,700
Convertible note	$ 5,000
Percentage of equity shares from convertible debt	9.90%				15.10%
Remaining convertible debt after conversion of part of debt	$ 3,300
Maximum percentage of entity's total assets invested on single property					5.00%
Bayonne Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Number of stories in building					6
Prime Health Care Services [Member]
Real Estate And Lending Activities [Line Items]
Percentage of entity revenue from affiliates					26.10%		29.90%
Percentage of total assets accounted					20.00%		29.70%			0.00%
Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Number of facilities acquired					7
Number of states					7
Monroe Hospital [Member]
Real Estate And Lending Activities [Line Items]
Revenue contributed by the acquired entity					$ 16,900
Advanced amount of working capital loan agreement					28,600
Interest receivable					$ 5,600
Period past due, in days					90
Impairment of working capital loan recognized								$ 12,000
Valuation allowance for rent					$ 2,500
Net investment to maximum exposure					33,500
Impairment of working capital loan estimation-patient receivables considered for first priority secured interest					5,000
Impairment of working capital loan estimation-cash balance considered for first priority secured interest					$ 4,000
Impairment of working capital loan estimation-membership interest of operator/lessee considered for first priority secured interest					100.00%
Rehabilitation Facility [Member]
Real Estate And Lending Activities [Line Items]
Number of facilities acquired					5
Florence Facility [Member]
Real Estate And Lending Activities [Line Items]
Term of lease, years \| yr					25
Costs of land and building					$ 30,000
Denham Springs Facility [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate					4,200
Business Acquisition, Cost of Acquired Entity, Purchase Price					4,200
Business Acquisition, Cost of Acquired Entity, Purchase Price					4,200
Ernest Health Holdings, LLC [Member]
Real Estate And Lending Activities [Line Items]
Combined purchase price and investment amount											$ 396,500
Purchase price of real estate											200,000
First mortgage loan											100,000
Acquisition loan made					93,200						93,200
Capital contribution											3,300
Total investment					$ 96,500
Preferential rate of return on loan amount					15.00%
Preferential return on remaining earnings					79.00%
Revenue contributed by the acquired entity					$ 3,900
Income contributed by the acquired entity					3,900
Acquisition related costs					$ 3,400
Percentage of entity revenue from affiliates					9.00%
Percentage of total assets accounted					19.20%
Business Acquisition, Cost of Acquired Entity, Purchase Price											200,000
Business Acquisition, Cost of Acquired Entity, Purchase Price											$ 200,000
Business Acquisitions [Member]
Real Estate And Lending Activities [Line Items]
Working capital loan to the joint venture			$ 5,200
Ownership interest in equity			51.00%
Retained ownership in operating entity			49.00%
Revenue contributed by the acquired entity						$ 3,200
Income contributed by the acquired entity						2,000
Acquisition related costs						$ 2,000
Number of business acquisitions in period									5
Business Acquisitions [Member] \| Gilbert Hospital [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate				$ 17,100
Date acquired					January 4, 2011
Number of beds acquired				19
Age of real estate acquired \| yr				4
Lease expiration date				May 2022
Business Acquisition, Cost of Acquired Entity, Purchase Price				$ 17,100
Business Acquisition, Cost of Acquired Entity, Purchase Price				$ 17,100
Business Acquisitions [Member] \| Atrium Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate			$ 23,500
Date acquired					January 31, 2011
Number of beds acquired			60
Lease expiration date			June 2024
Date of construction			2009
Business Acquisition, Cost of Acquired Entity, Purchase Price			$ 23,500
Business Acquisition, Cost of Acquired Entity, Purchase Price			23,500
Business Acquisitions [Member] \| Bayonne Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate													$ 58,000
Term of lease, years													15
Number of lease extension options in current lease contract													6
Term of lease extension, years													5
Date acquired					February 4, 2011
Number of beds acquired													278
Business Acquisition, Cost of Acquired Entity, Purchase Price													$ 58,000
Business Acquisition, Cost of Acquired Entity, Purchase Price													$ 58,000
Business Acquisitions [Member] \| Alvarado Hospital [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate												$ 70,000
Term of lease, years												10
Date acquired					February 9, 2011
Number of beds acquired												306
Business Acquisition, Cost of Acquired Entity, Purchase Price												$ 70,000
Business Acquisition, Cost of Acquired Entity, Purchase Price												$ 70,000
Business Acquisitions [Member] \| Northland LTACH Hospital [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate		$ 19,500
Date acquired					February 14, 2011
Number of beds acquired		35
Lease expiration date		2028
Date of construction		April 2008
Existing mortgage loan		$ 16,000
Business Acquisition, Cost of Acquired Entity, Purchase Price		19,500
Business Acquisition, Cost of Acquired Entity, Purchase Price		$ 19,500
Business Acquisitions [Member] \| Vibra Health Care [Member]
Real Estate And Lending Activities [Line Items]
Payments to acquire equity method investments			$ 1,300
Ownership interest in equity			19.00%
United States [Member]
Real Estate And Lending Activities [Line Items]
Percentage of total assets accounted					24.00%
Maximum [Member]
Real Estate And Lending Activities [Line Items]
Percentage of rental rate					5.00%
Minimum [Member]
Real Estate And Lending Activities [Line Items]
Percentage of rental rate					2.00%
Key Management Personnel [Member] \| Ernest Health Holdings, LLC [Member]
Real Estate And Lending Activities [Line Items]
Capital contribution					$ 3,300

Real Estate And Lending Activities (List Of Assets Purchased As Part Of Acquisitions) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2011 USD ($)	Mar. 31, 2012 USD ($)
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	$ 194,579	$ 396,500
Land [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	16,151
Building [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	157,834
Net Investment In Direct Financing Leases [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total		200,000
Mortgage Loans [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total		100,000
Other Loans [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	5,233	93,200
Equity Investments [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	1,268	3,300
Intangible Lease Assets [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	$ 14,093
Weighted average useful life of acquired intangible lease assets (in years)	23.1

Real Estate And Lending Activities (Unaudited Pro Forma Consolidated Financial Data) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Real Estate And Lending Activities [Abstract]
Total revenues	$ 50,735	$ 50,020
Net income	$ 19,647	$ 21,220
Net income per share/unit - diluted	$ 0.14	$ 0.16

Real Estate And Lending Activities (Schedule Of Components Of Net Investments In DFL) (Details) - USD ($) $ in Thousands	Mar. 31, 2012	Dec. 31, 2011
Real Estate And Lending Activities [Abstract]
Minimum lease payments receivable	$ 901,400
Estimated residual values	200,000
Less unearned income	(901,115)
Net investment in direct financing leases	$ 200,285

Debt (Narrative) (Details) - USD ($)

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Mar. 09, 2012

Feb. 17, 2012

Oct. 31, 2011

Mar. 31, 2012

Sep. 30, 2011

Sep. 30, 2010

Jun. 30, 2010

Sep. 30, 2011

Sep. 30, 2010

Dec. 31, 2011

Mortgage loan assumed, maturity date

Jan. 01, 2018

LIBOR plus spread interest rate

2.25%

Initial spread interest rate

1.25%

Total senior notes available

^[1]

$ 900,225,000

$ 689,849,000

Other collateral assets

$ 6,700,000

$ 6,300,000

Hedge ineffectiveness and income statement effect in period

$ 0

Percentage of dividends paid from adjusted operating funds

120.00%

Restricted percentage for future dividend payment

115.00%

Restricted percentage for dividend payment for next year

95.00%

Percentage of dividends paid from operation funds

95.00%

Percentage of total unencumbered assets

150.00%

Interest Rate Contract [Member]

Fair value of the interest rate swaps

$ 11,700,000

$ 12,200,000

Interest Rate Contract One [Member]

Maturity date of interest rate swap

July 2016

Interest rate of derivative instrument

5.507%

Interest Rate Contract Two [Member]

Interest rate swap, amount fixed

$ 60,000,000

Maturity date of interest rate swap

October 2016

Interest rate of derivative instrument

5.675%

2006 Senior Unsecured Notes [Member]

Portion of debt instrument face amount

$ 125,000,000

$ 65,000,000

2012 Senior Unsecured Notes [Member]

Unsecured senior notes, value of offering

$ 200,000,000

Unsecured senior note, maturity date

6.375%

February 15, 2022

Net proceeds, after underwriting discount

$ 196,500,000

Exchangeable Senior Notes [Member]

$ 200,000,000

9.25%

$ 11,000,000

Term Loans [Member]

9.25%

6.20%

2012 Term Loan [Member]

Revolving credit facility

$ 70,000,000

Term loan facility, maturity period

Mar. 09, 2016

Paid off term loan

$ 100,000,000

Revolving Credit Facilities [Member]

Federal Funds Rate [Member]

$ 89,600,000

Credit facilities, basis spread on variable rate

0.50%

Eurodollar Rate [Member]

Credit facilities, basis spread on variable rate

1.00%

Maximum [Member] | 2012 Term Loan [Member]

Revolving credit facilities, balance amount

$ 400,000,000

Minimum [Member] | 2012 Term Loan [Member]

Revolving credit facilities, balance amount

$ 330,000,000

[1]	Level II: Fair value based on quoted prices for similar or identical instruments in active or inactive markets, respectively, or calculated utilizing model-derived valuations in which significant inputs or value drivers are observable in active markets.

Debt (Summary Of Debt) (Details) - USD ($)

3 Months Ended

12 Months Ended

Mar. 31, 2012

Dec. 31, 2011

Feb. 17, 2012

Revolving Credit Facilities [Member]

^[1]

$ 900,225,000

$ 689,849,000

2006 Senior Unsecured Notes [Member]

$ 89,600,000

Interest Rate

Variable

2011 Senior Unsecured Notes [Member]

$ 125,000,000

Interest Rate

Various

$ 450,000,000

2012 Senior Unsecured Notes [Member]

6.875%

$ 200,000,000

Exchangeable Senior Notes [Member]

6.375%

$ 11,000,000

Unamortized discount

(147,000)

(180,000)

Debt instrument, net

10,853,000

$ 10,820,000

9.25%

Term Loans [Member]

Debt instrument, net

$ 114,372,000

$ 14,429,000

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

9.25%

6.20%

Interest Rate

Various

[1]	Level II: Fair value based on quoted prices for similar or identical instruments in active or inactive markets, respectively, or calculated utilizing model-derived valuations in which significant inputs or value drivers are observable in active markets.

Debt (Principal Payments Due For Debt) (Details) $ in Thousands	Mar. 31, 2012 USD ($)
Debt [Abstract]
2012	$ 174
2013	11,249
2014	266
2015	283
2016	225,299
Thereafter	663,101
Total	$ 900,372

Common Stock/Partner's Capital (Details) $ / shares in Units, $ in Thousands		3 Months Ended
	Feb. 07, 2012 USD ($) $ / shares shares	Mar. 31, 2012 USD ($) shares	Dec. 31, 2011 shares
Class of Stock [Line Items]
Common stock, shares issued		134,524,000	110,786,000
Proceeds from issuance of common stock \| $		$ 220,193
Public Offering [Member]
Class of Stock [Line Items]
Common stock, shares issued	23,575,000
Public offering price for common stock per share \| $ / shares	$ 9.75
Underwriters' purchase of shares to cover overallotment	3,075,000
Proceeds from issuance of common stock \| $	$ 220,200
MPT Operating Partnership, L.P. [Member]
Class of Stock [Line Items]
Common stock, shares issued		23,575,000
Proceeds from issuance of common stock \| $		$ 220,193
Ownership interest in Operating Partnership		99.80%
Number of other partners		3
Employee [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage		2
Director [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage		1

Stock Awards (Details) - shares	3 Months Ended	12 Months Ended
Stock Awards (Details) - shares	Mar. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	7,441,180
Common stock remaining for future stock awards	1,438,541
Stock awards vesting period in years	two
Time-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, shares issued	275,464	292,803
Stock awards vesting period in years	three
Performance-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, shares issued	252,566	253,655
Stock awards vesting period in years	three
Multi-Year Performance-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, multi-year performance-based awards	649,793	600,000
Stock awards vesting period in years	three

Fair Value Of Financial Instruments (Summary Of Fair Value Information Of Financial Instruments) (Details) - USD ($)
$ in Thousands

Mar. 31, 2012

Dec. 31, 2011

Interest and rent receivables

^[1]

$ 33,650

$ 29,862

Loans

^[1]

430,207

239,839

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

^[1]

(900,225)

(689,849)

Fair Value [Member]

Interest and rent receivables

^[1]

26,406

22,866

Loans

^[1]

433,033

243,272

^[1]

$ (909,159)

$ (688,032)

[1]	Level II: Fair value based on quoted prices for similar or identical instruments in active or inactive markets, respectively, or calculated utilizing model-derived valuations in which significant inputs or value drivers are observable in active markets.

Fair Value Of Financial Instruments (Schedule Of Equity Interest) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Schedule of Investments [Line Items]
Fair Value	$ 196,500
Cost	196,500
Investment income interest	(16)	$ (14)
Mortgage Loans [Member]
Schedule of Investments [Line Items]
Fair Value	100,000
Cost	100,000
Acquisition Loan [Member]
Schedule of Investments [Line Items]
Fair Value	93,200
Cost	93,200
Equity Investments [Member]
Schedule of Investments [Line Items]
Fair Value	3,300
Cost	3,300
Ernest Health Holdings, LLC [Member]
Schedule of Investments [Line Items]
Investment income interest	$ 2,000

Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14.Column E.2,3)
-URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611322-123010

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 5
-Subparagraph (SX 210.12-13.Column C.6)
-URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611282-123010

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12.Column C.3,4)
-URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611133-123010

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-12C.Column C.7)
-URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611225-123010

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 12C
-Paragraph 7
-Article 12

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 12C
-Paragraph Column C
-Article 12

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 12
-Paragraph 3, 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Paragraph Column C
-Article 12

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 13
-Paragraph 6
-Article 12

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 13
-Paragraph Column C
-Article 12

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 14
-Paragraph 2, 3
-Article 12

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 14
-Paragraph Column E
-Article 12

Discontinued Operations (Narrative) (Details) $ in Millions	Dec. 30, 2011 USD ($)
MountainView Regional Rehabilitation Hospital [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate	$ 21.1
Gain on sale of real estate	2.3
Sherman Oaks Hospital [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate	20.0
Gain on sale of real estate	3.1
wrote-off rent receivables	$ 1.2

Discontinued Operations (Schedule Of Discontinued Operations) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Discontinued Operations [Abstract]
Revenues	$ 121	$ 1,351
Gain on sale		5
Income (loss)	$ 121	$ 1,172
Earnings per share/unit - diluted		$ 0.01

Gain (loss) after tax expense or benefit, not previously recognized and resulting from the sale of a business component, which is recognized at the date of sale. A gain (loss) reflects the amount by which the consideration received exceeds (is exceeded by) the net carrying amount (reflecting previous provisions for loss on disposal, if any) of the disposal group.

This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 47
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 03
-Paragraph 15

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 13
-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.12)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.14)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Condensed Financial Statements, Captions [Line Items]

Earnings Per Share/Common Unit (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 10,485	$ 9,652
Basic weighted-average common shares	124,906	110,400
Dilutive weighted-average common shares/units	124,906	110,408
Stock Options [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Options excluded from earnings per share/unit	100	100
Medical Properties Trust, Inc. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 10,485	$ 9,652
Non-controlling interests' share in continuing operations	(42)	(44)
Participating securities' share in earnings	(252)	(316)
Income from continuing operations, less participating securities' share in earnings	10,191	9,292
Income from discontinued operations attributable to MPT common stockholders	121	1,172
Net income, less participating securities' share in earnings	$ 10,312	$ 10,464
Basic weighted-average common shares	124,906	110,400
Dilutive share options		8
Dilutive weighted-average common shares/units	124,906	110,408
MPT Operating Partnership, L.P. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 10,485	$ 9,668
Non-controlling interests' share in continuing operations	(42)	(44)
Participating securities' share in earnings	(252)	(316)
Income from continuing operations, less participating securities' share in earnings	10,191	9,308
Income from discontinued operations attributable to MPT common stockholders	121	1,172
Net income, less participating securities' share in earnings	$ 10,312	$ 10,480
Basic weighted-average common shares	124,906	110,400
Dilutive share options		8
Dilutive weighted-average common shares/units	124,906	110,408

Condensed Consolidating Financial Information (Summary Of Condensed Consolidated Balance Sheet) (Details) - USD ($)
$ in Thousands

Mar. 31, 2012

Dec. 31, 2011

Mar. 31, 2011

Dec. 31, 2010

Land, buildings and improvements and intangible lease assets

$ 1,282,373

$ 1,275,399

265,000

165,000

1,747,658

1,440,399

(112,484)

(103,737)

1,635,174

1,336,662

200,285

126,500

102,726

$ 7,010

$ 98,408

^[1]

33,650

29,862

35,493

33,993

165,207

74,839

52,438

43,792

2,048,462

1,621,874

^[1]

900,225

689,849

62,278

51,125

22,544

23,307

28,668

28,778

Non-controlling interests

1,013,715

793,059

1,034,747

828,815

Condensed Financial Statements, Captions [Line Items]

2,048,462

1,621,874

Parent [Member]

27,121

21,955

1,035,137

829,205

1,062,258

851,160

27,511

22,345

Total Medical Properties Trust Inc. stockholder's equity

27,511

22,345

1,034,747

828,815

1,034,747

828,815

Subsidiary Issuers [Member]

1,062,258

851,160

Condensed Financial Statements, Captions [Line Items]

Land, buildings and improvements and intangible lease assets

708

708

708

124,850

101,230

6,699

96,822

412

399

177

1,275,634

872,382

519,209

489,858

32,868

27,284

1,953,858

1,491,367

885,853

635,820

32,317

25,783

551

559

Total Medical Properties Trust Inc. stockholder's equity

918,721

662,162

1,035,137

829,205

1,035,137

829,205

Subsidiary Guarantors [Member]

1,953,858

1,491,367

Condensed Financial Statements, Captions [Line Items]

Land, buildings and improvements and intangible lease assets

1,153,464

1,147,161

165,000

1,318,464

1,312,161

(99,789)

(91,822)

1,218,675

1,220,339

1,564

1,409

1,387

24,562

22,529

25,050

24,005

(864,229)

(889,585)

42,969

43,008

1,606

1,727

450,197

423,432

1,862

2,576

16,782

17,488

28,028

27,874

Total Medical Properties Trust Inc. stockholder's equity

46,672

47,938

403,525

375,494

403,525

375,494

Non-Guarantor Subsidiaries [Member]

450,197

423,432

Condensed Financial Statements, Captions [Line Items]

Land, buildings and improvements and intangible lease assets

128,201

100,000

428,486

128,201

(12,695)

(11,915)

415,791

116,286

200,285

300

199

8,676

6,934

10,443

9,988

165,030

74,662

(438,526)

(4,752)

17,964

14,781

179,464

217,986

14,372

54,029

588

421

5,211

5,260

640

904

Total Medical Properties Trust Inc. stockholder's equity

20,811

60,614

158,653

157,372

158,653

157,372

Condensed Financial Statements, Captions [Line Items]

179,464

217,986

Eliminations [Member]

(1,597,315)

(1,362,071)

Total Medical Properties Trust Inc. stockholder's equity

(1,597,315)

(1,362,071)

(1,597,315)

(1,362,071)

(1,597,315)

(1,362,071)

Total Consolidated [Member]

(1,597,315)

(1,362,071)

Condensed Financial Statements, Captions [Line Items]

Land, buildings and improvements and intangible lease assets

1,282,373

1,275,399

265,000

165,000

1,747,658

1,440,399

(112,484)

(103,737)

1,635,174

1,336,662

200,285

126,500

102,726

$ 7,010

$ 98,408

33,650

29,862

35,493

33,993

165,207

74,839

52,438

43,792

2,048,462

1,621,874

900,225

689,849

62,278

51,125

22,544

23,307

28,668

28,778

Total Medical Properties Trust Inc. stockholder's equity

1,013,715

793,059

1,034,747

828,815

1,034,747

828,815